Skip to main content
Equibles
EOLS logo

EOLS · Evolus, Inc. · Metrics

Track EOLS — free

Use EOLS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EOLS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.84 -0.07 (-0.88%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$517.84M
Shares
66.05M

EOLS metrics

71 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.84
Market cap
$517.84M

Price action

20 metrics
Price change (1W)
-15.7%
Price change (30D)
-2.2%
Price change (3M)
+16.5%
Price change (6M)
+56.5%
Price change (YTD)
+17.9%
Price change (1Y)
+4.4%
Trailing year
Price change (5Y)
-3.3%
52-week high
$9.30
52-week low
$3.94
Change from 52-week high
-15.7%
Change from 52-week low
+99.0%
Annualized volatility
67.4%
Annualized volatility (3M)
62.9%
Beta
1.1
RSI (14D)
43.5
Price vs SMA 50
+6.3%
Price vs SMA 200
+28.8%
Avg volume (3M)
922,307
Relative volume
0.6
Average dollar volume
$6.87M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
66.05M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.0×
reciprocal yield 50.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 61.1%
P / book
—
FCF yield
-3.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.6%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.8×
reciprocal yield 35.2%
EV / revenue historical average (5Y)
3.3×
reciprocal yield 29.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
66.7%
Operating margin
-5.9%
Trailing 12 months
Net margin
-10.8%
Gross profit (TTM)
$211.21M
Operating profit (TTM)
−$18.67M
Net income (TTM)
−$34.33M
Trailing 12 months
Diluted EPS (TTM)
$-0.51
FCF margin
-5.8%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.36

Growth

11 metrics
Revenue growth YoY
+21.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$316.49M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.2%
Year over year · more shares
Revenue CAGR (3Y)
+26.0%
Revenue CAGR (5Y)
+39.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-13.8%
Debt / equity
—
Current ratio
1.7
EBITDA (TTM)
−$9.79M
Free cash flow (TTM)
−$18.28M
Quick ratio
1.3
Interest coverage
-1.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$111.57M
Latest balance sheet
Cash & equivalents
$45.17M
Total assets
$248.02M
Total debt
$156.74M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$15.38M
Capital expenditures (TTM)
$2.90M
R&D (TTM)
$9.66M
SG&A (TTM)
$216.50M
Stock compensation (TTM)
$21.02M
R&D / revenue
3.1%
Stock compensation / revenue
6.6%

Ownership (13F)

3 metrics
13F filers
160
13F filer change QoQ
+11
Institutional ownership
74.6%

Short interest

3 metrics
Short interest
8.1%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$950,019
Insider-sentiment score
32 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1570562 CUSIP 30052C107 13F (30d) 83 filings 83 filers Visit website Investor relations